Subscribe to Newsletter

Gary Siuzdak

The Power List 2017

Gary Siuzdak

Professor and Director, Scripps Center for Metabolomics, The Scripps Research Institute, California, USA.

Most exciting current project
In three words: metabolomics activity screening (MAS) – this project is taking metabolomics beyond biomarker discovery and towards identifying biologically active endogenous metabolites that can be used to intentionally modulate phenotype.

Career highlight
In two words: phenotype modulation – the culmination of creating the cloud-based XCMS/METLIN metabolomics discovery platform with over 20,000 users, and developing it for metabolite activity screening. We have multiple examples of its application, using metabolites in stem cell activation, chronic pain amelioration and, most recently, in oligodendrocyte generation for multiple sclerosis.

Why metabolomics?
In a word: phenotype – metabolites are the most downstream components in the biochemical cascade and therefore are closest to the phenotype. Thus, metabolomics can be used to identify metabolites for phenotype modulation; I believe this is where the real power of metabolomics lies.

Part of the Power List 2017

The Magnificent Tens

The Magnificent Tens
After 2016’s celebration of women in analytical science, we return to the Top 100 for 2017.
But there’s a twist. This summer, we asked you to nominate scientists in ten categories – from the stars of separation science, to omics explorers, to the mentors training the next generation.

Go to The Power List 2017

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine